Detection of fluorine labeled Herceptin using cellular 19F MRI ex vivo

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 4, 2010, Pages 894-900

  Bartusik, Dorota ^a   Tomanek, Boguslaw ^a,b,c,d  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

19F MRI; Breast cancer cells; Drug efficacy

Indexed keywords

FLUORINE; LIPOFECTAMINE; LIPOPLEX; PERFLUOROOCTYL BROMIDE; PLASMID DNA; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; EX VIVO STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOREACTORS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; FEMALE; FLUOROCARBONS; HUMANS; INHIBITORY CONCENTRATION 50; LIPIDS; MAGNETIC RESONANCE IMAGING; TIME FACTORS;

EID: 72149113310     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.10.008     Document Type: Article

References (20)

1. Artemov D., Mori N., Ravi R., and Bhujwalla Z.M. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 63 (2003) 2723-2727
2. Subramanian A., and Mokbel K. The role of Herceptin in early breast cancer. Int. Semin. Surg. Oncol. 5 (2008) 9
3. Wang S.C., Zhang L., Hortobagyi G.N., and Hung M.C. Targeting HER-2: recent developments and future directions for breast cancer patients. Semin. Oncol. 28 6 Suppl 18 (2001) 21-29
4. Gianni L. The "Other" signaling of trastuzumab: antibodies are immunocompetent drugs. J. Clin. Oncol. 26 (2008) 1778-1780
5. Kim J.K., Kucharczyk W., and Henkelman R.M. Cavernous hemangiomas: dipolar susceptibility artifacts at MR imaging. Radiology 187 (1993) 735-741
6. Liu W., and Frank J.A. Detection and quantification of magnetically labeled cells by cellular MRI. Eur. J. Radiol. 70 (2009) 258-264
7. 19F magnetic resonance ex vivo imaging of three-dimensional cultured breast cancer cells to study the effect of δ-tocopherol. Anal. Biochem. 387 (2009) 315-317
8. Doeppler E.T.H., Yan I.K., Goodison S., and Storz P. Protein kinase D1 regulates MMP expression and inhibits breast cancer cell invasion. Breast Cancer Res. 11 (2009) R13
9. Takahashi K., and Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem. Pharmacol. 67 (2004) 315-324
10. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., and Martin M. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269 4 (1994) 2550-2561
11. Srinivas M., Morel P.A., Ernst L.A., Laidlaw D.H., and Ahrens E.T. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 58 4 (2007) 725-734
12. 19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl β-d-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse. FASEB J. 21 (2007) 2014-2019
13. 19F NMR probe at 4.7 T. Artif. Cells Blood Substit. Immob. Biotechnol. 22 (1995) 1361-1367
14. King A.T., Mulligan B.J., and Lowe K.C. Perfluorochemicals and cell culture. Bio/Technology 7 (1989) 1037-1042
15. Lanza G.M., and Wickline S.A. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr. Probl. Cardiol. 28 (2003) 625-653
16. Abbott A. Cell culture: Biology's new dimension. Nature 424 (2003) 870-872
17. Fischbach C., Kong H.J., Hsiong S.X., Evangelista M.B., Yuen W., and Mooney D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl. Acad. Sci. U.S.A. 106 2 (2009) 399-404
18. Kauraniemi P., Hautaniemi S., Autio R., Astola J., Monni O., Elkahloun A., and Kallioniemi A. Effects of Herceptin treatment on global gene expression patterns in HER-2 amplified and nonamplified breast cancer cell lines. Oncogene 23 (2004) 1010-1013
19. Vitu-Loas L., Thomas C., Chavaudra N., and Guichard M. Radiosensitivity, blood perfusion and tumor oxygenation after perfluorobron emulsion injection. Radiother. Oncol. 27 (1993) 149-155
20. 19F NMR Spectroscopy. Artif. Cells Blood Substit. Immob. Biotechnol. 22 (1995) 1243-1250